Aethlon Medical, Inc. (AEMD)
AEMD Stock Price Chart
Explore Aethlon Medical, Inc. interactive price chart. Choose custom timeframes to analyze AEMD price movements and trends.
AEMD Company Profile
Discover essential business fundamentals and corporate details for Aethlon Medical, Inc. (AEMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
4 Mar 1999
Employees
14.00
Website
https://www.aethlonmedical.comCEO
James Frakes
Description
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
AEMD Financial Timeline
Browse a chronological timeline of Aethlon Medical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.79.
Earnings released on 10 Jun 2026
EPS came in at $4.08 surpassing the estimated -$2.46 by +265.85%.
Earnings released on 12 Feb 2026
EPS came in at -$2.45 falling short of the estimated -$2.01 by -21.89%.
Earnings released on 12 Nov 2025
EPS came in at -$3.74 falling short of the estimated -$1.70 by -120.00%.
Stock split effective on 20 Oct 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Aug 2025
EPS came in at -$8.50 falling short of the estimated -$6.80 by -25.00%.
Earnings released on 26 Jun 2025
EPS came in at -$7.28 falling short of the estimated -$0.98 by -642.86%, while revenue for the quarter reached $172.12k .
Stock split effective on 9 Jun 2025
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Feb 2025
EPS came in at -$0.13 surpassing the estimated -$0.22 by +40.91%.
Earnings released on 13 Nov 2024
EPS came in at -$0.20 matching the estimated -$0.20.
Earnings released on 14 Aug 2024
EPS came in at -$0.34 surpassing the estimated -$0.44 by +22.73%.
Earnings released on 27 Jun 2024
EPS came in at -$0.91 surpassing the estimated -$1.18 by +22.88%.
Earnings released on 14 Feb 2024
EPS came in at -$1.37 falling short of the estimated -$1.23 by -11.38%.
Earnings released on 14 Nov 2023
EPS came in at -$1.22 surpassing the estimated -$1.35 by +9.63%.
Stock split effective on 5 Oct 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Aug 2023
EPS came in at -$1.30 falling short of the estimated -$1.20 by -8.33%.
Earnings released on 28 Jun 2023
EPS came in at -$1.10 surpassing the estimated -$1.60 by +31.25%, while revenue for the quarter reached $574.25k .
Earnings released on 13 Feb 2023
EPS came in at -$1.20 falling short of the estimated -$0.40 by -200.00%.
Earnings released on 14 Nov 2022
EPS came in at -$1.80 surpassing the estimated -$2.30 by +21.74%, while revenue for the quarter reached $574.00k , beating expectations by +725.31%.
Earnings released on 9 Aug 2022
EPS came in at -$1.90 surpassing the estimated -$2.40 by +20.83%.
Earnings released on 28 Jun 2022
EPS came in at -$2.50 falling short of the estimated -$1.20 by -108.33%, while revenue for the quarter reached $13.12k , missing expectations by -98.18%.
Earnings released on 14 Feb 2022
EPS came in at -$1.60 falling short of the estimated -$1.30 by -23.08%, while revenue for the quarter reached $17.12k , missing expectations by -91.94%.
Earnings released on 9 Nov 2021
EPS came in at -$1.30 surpassing the estimated -$1.50 by +13.33%, while revenue for the quarter reached $131.97k , missing expectations by -30.54%.
Earnings released on 9 Aug 2021
EPS came in at -$1.60 falling short of the estimated -$1.30 by -23.08%, while revenue for the quarter reached $131.97k , missing expectations by -0.03%.
AEMD Stock Performance
Access detailed AEMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
